US equities |
NVDA $238.90 ▲+2.12% SPCX $171.09 ▲+7.63% MU $1,063.96 ▼-1.02% TSLA $378.73 ▲+2.20% WBD $30.95 ▲+0.03% MSFT $525.18 ▲+1.48% AAPL $332.89 ▼-0.24% META $741.90 ▲+1.90%
FinancialContent

Seelos Therapeutics, Inc. - Common Stock (NQ:SEEL)

1.280 UNCHANGED
Last Price Updated: 4:00 PM EDT, Oct 15, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Seelos Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
News headline image
Psychedelic Stocks Jumped 10% Last Week ↗
The FDA released a positive draft guidance for developing psychedelic treatments and the 6 largest stocks in the Psychedelic Drug Stocks Index responded accordingly 
Via Talk Markets
News headline image
Upward Trend In Largest Psychedelic Compound-Based R&D Stocks Continues ↗
Our Psychedelic Drug Stocks Index, which consists of the 6 largest psychedelic compound-based research & development companies, was up 3.4% this week, up 7.1% in June, up 6.3% in May, and is now up... 
Via Talk Markets
News headline image
Analyst Ratings for Seelos Therapeutics ↗
 
Via Benzinga
News headline image
Upward Trend In Major Psychedelic Compound-Based Research & Development Stocks Continue ↗
There are 6 constituents in our munKNEE Psychedelic Drug Stocks Index and 5 of them advanced this week and are now all up MTD. 
Via Talk Markets
News headline image
Major Psychedelic Compound-Based Research & Development Stocks: June Update ↗
Psychedelic Drug Stocks Index has been revamped with the removal of Cybin (CYBN) which has dropped below $100M in market capitalization leaving 6 constituents in the Index 
Via Talk Markets
News headline image
Seelos Therapeutics Pauses Spinocerebellar Ataxia Study Citing Financial Considerations ↗
 
Via Benzinga
News headline image
May Summary Of Largest Psychedelic Compound-Based Drug Stock Performances ↗
Only two of the seven largest psychedelic compound-based drug stocks tracked, advanced in May. 
Via Talk Markets
News headline image
Why Nvidia Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers QualTek Services Inc. (NASDAQ: QTEK) shares jumped 127.2% to $0.1740 after dropping around 21% on Friday. Qualtek Services recently filed voluntarily petitions for Chapter 11 bankruptcy. 
Via Benzinga
News headline image
Why Seelos Therapeutics Shares Are Trading Lower By 10%; Here Are 20 Stocks Moving Premarket ↗
Gainers QualTek Services Inc. (NASDAQ: QTEK) shares rose 206.7% to $0.2350 in pre-market trading after dropping around 21% on Friday. Qualtek Services recently filed voluntarily petitions for Chapter... 
Via Benzinga
News headline image
Psyched: New Psilocybin Forms, LSD Anxiety Study, UK's Parliamentary Debate And More ↗
Biotech Company Discovers What May Be The First New Compounds Of Psilocybin In History NY-based biotech platform Terran Biosciences announced the publication of an international PCT patent application... 
Via Benzinga
News headline image
Seelos Therapeutics Positive Q1 Financials Make For 'The Most Important Year' In Company's History ↗
Clinical-stage biopharma company Seelos Therapeutics Inc. (NASDAQ: SEEL) reported financial results and clinical updates corresponding to the first quarter ended March 31, 2023. Quarterly numbers... 
Via Benzinga
News headline image
April Psychedelic Drug Stocks Recap: The Ups And Downs ↗
Via Talk Markets
News headline image
Seelos Therapeutics, Compass Pathways Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Seelos Therapeutics, ATAI Life Sciences Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Cybin, Mind Medicine Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From April 18, 2023 ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From April 17, 2023 ↗
 
Via Benzinga
News headline image
ATAI Life Sciences, Seelos Therapeutics Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From April 13, 2023 ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From April 12, 2023 ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From April 11, 2023 ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From April 10, 2023 ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From April 7, 2023 ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From April 6, 2023 ↗
 
Via Benzinga
News headline image
Compass Pathways, GH Research Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From April 4, 2023 ↗
 
Via Benzinga
News headline image
Seelos Therapeutics, ATAI Life Sciences Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Largest Psychedelic Stocks -3.4% In March ↗
The munKNEE Psychedelic Drug Stocks Index was down 3.4% in March but is still +1.2% YTD. The best news is the continuing high price targets being set by analysts. 
Via Talk Markets
News headline image
Psychedelic Stock Gainers And Losers From March 31, 2023 ↗
 
Via Benzinga
News headline image
Seelos Therapeutics, Mind Medicine Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >